NeoChord Inc.

NeoChord Inc is a venture backed medical device company that has developed a proprietary device that allows mitral valve repair. The company has an exclusive worldwide license to the technology and is currently working on additional minimally invasive technologies for the treatment of  structural heart disease.

NeoChord DS1000 may offer patients a less invasive procedure choice. This system is intended to replace damaged chordae by delivering artificial chordae tendinae in a beating heart, using minimally invasive techniques.